Davies Sarah, Zhang Jimmy, Yi Yongjun, Burge Eric R, Desjardins Marc, Austin Peter C, van Walraven Carl
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, ICES, Toronto, ON, Canada.
Antimicrob Steward Healthc Epidemiol. 2024 Apr 29;4(1):e66. doi: 10.1017/ash.2024.58. eCollection 2024.
Many factors have been associated with the risk of toxigenic diarrhea (TCdD). This study derived and internally validated a multivariate model for estimating the risk of TCdD in patients with diarrhea using readily available clinical factors.
A random sample of 3,050 symptomatic emergency department or hospitalized patients undergoing testing for toxigenic at a single teaching hospital between 2014 and 2018 was created. Unformed stool samples positive for both glutamate dehydrogenase antigen by enzyme immunoassay and gene by polymerase chain reaction were classified as TCdD positive. The TCdD Model was created using logistic regression and was modified to the TCdD Risk Score to facilitate its use.
8.1% of patients were TCdD positive. TCdD risk increased with abdominal pain (adjusted odds ratio 1.3; 95% CI, 1.0-1.8), previous diarrhea (2.5, 1.1-6.1), and prior antibiotic exposure, especially when sampled in the emergency department (4.2, 2.5-7.0) versus the hospital (1.7, 1.3-2.3). TCdD risk also increased when testing occurred earlier during the hospitalization encounter, when age and white cell count increased concurrently, and with decreased eosinophil count. In internal validation, the TCdD Model had moderate discrimination (optimism-corrected C-statistic 0.65, 0.62-0.68) and good calibration (optimism-corrected Integrated Calibration Index [ICI] 0.017, 0.001-0.022). Performance decreased slightly for the TCdD Risk Score (C-statistic 0.63, 0.62-0.63; ICI 0.038, 0.004-0.038).
TCdD risk can be predicted using readily available clinical risk factors with modest accuracy.
许多因素与产毒性腹泻(TCdD)风险相关。本研究利用易于获取的临床因素,推导并内部验证了一个用于估计腹泻患者TCdD风险的多变量模型。
选取了2014年至2018年间在一家教学医院接受产毒性检测的3050例有症状的急诊科或住院患者作为随机样本。酶免疫测定谷氨酸脱氢酶抗原和聚合酶链反应检测基因均呈阳性的不成形粪便样本被分类为TCdD阳性。使用逻辑回归创建了TCdD模型,并将其修改为TCdD风险评分以方便使用。
8.1%的患者TCdD呈阳性。TCdD风险随着腹痛(调整比值比1.3;95%置信区间,1.0 - 1.8)、既往腹泻(2.5,1.1 - 6.1)以及既往抗生素暴露而增加,尤其是在急诊科采样时(4.2,2.5 - 7.0)相较于在医院采样时(1.7,1.3 - 2.3)。当在住院期间更早进行检测、年龄和白细胞计数同时增加以及嗜酸性粒细胞计数减少时,TCdD风险也会增加。在内部验证中,TCdD模型具有中等区分度(乐观校正C统计量0.65,0.62 - 0.68)和良好校准(乐观校正综合校准指数[ICI] 0.017,0.001 - 0.022)。TCdD风险评分的性能略有下降(C统计量0.63,0.62 - 0.63;ICI 0.038,0.004 - 0.038)。
使用易于获取的临床风险因素可以对TCdD风险进行适度准确的预测。